- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
有加速上涨趋势。
- 长期趋势：
已有284家主力机构披露2025-06-30报告期持股数据，持仓量总计7.24亿股，占流通A股46.02%
- 波段诊断：
-
技术面诊股
诊断结果：7.5技术面打败了73%的股票
技术面评分前10的股票
近期的平均成本为16.16元。多头行情中，并且有加速上涨趋势。
平均成本
近期的平均成本为16.16元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"16.16","date":1760326638,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑输大盘，跑赢行业平均水平。
[{"date":"2025.10.13","stock":"-0.06","trade":"-1.02","ind":"-0.93"},{"date":"2025.10.10","stock":"0.56","trade":"-0.88","ind":"-2.70"},{"date":"2025.10.09","stock":"1.76","trade":"-0.38","ind":"1.47"},{"date":"2025.09.30","stock":"-0.19","trade":"0.69","ind":"0.35"},{"date":"2025.09.29","stock":"-0.62","trade":"0.77","ind":"2.05"},{"date":"2025.09.26","stock":"-0.06","trade":"-1.00","ind":"-1.76"},{"date":"2025.09.25","stock":"-0.68","trade":"-0.53","ind":"0.67"},{"date":"2025.09.24","stock":"1.00","trade":"1.74","ind":"1.80"},{"date":"2025.09.23","stock":"-0.68","trade":"-2.59","ind":"-0.29"},{"date":"2025.09.22","stock":"-0.62","trade":"-0.03","ind":"0.67"},{"date":"2025.09.19","stock":"-0.73","trade":"-1.89","ind":"-0.04"},{"date":"2025.09.18","stock":"-1.27","trade":"-0.43","ind":"-1.06"},{"date":"2025.09.17","stock":"-1.08","trade":"-0.76","ind":"1.16"},{"date":"2025.09.16","stock":"0.36","trade":"-0.13","ind":"0.45"},{"date":"2025.09.15","stock":"-0.66","trade":"-0.30","ind":"0.63"},{"date":"2025.09.12","stock":"-0.77","trade":"0.40","ind":"-0.43"},{"date":"2025.09.11","stock":"1.38","trade":"0.93","ind":"3.36"},{"date":"2025.09.10","stock":"-1.24","trade":"-0.72","ind":"0.38"},{"date":"2025.09.09","stock":"-0.24","trade":"-1.80","ind":"-1.23"},{"date":"2025.09.08","stock":"0.59","trade":"0.58","ind":"0.61"},{"date":"2025.09.05","stock":"2.00","trade":"2.42","ind":"3.89"}]
华兰生物,深证成指,生物制品指数
压力支撑
该股压力位为16.12元，支撑位为15.96元。
[{"text":"\u538b\u529b\u4f4d","value":"16.12","date":1760284800,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"15.96","date":1760284800,"color":"0x0b52a1"}]
多空趋势
多头行情中，并且有加速上涨趋势。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：2.5资金面打败了9%的股票
主力控盘前10的股票
行业资金
生物制品行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：10月14日 13:07
| 机构今日流向(万元) | -750.72 | 机构5日流向(万元) | -3206.65 |
| 机构10日流向(万元) | -8087.20 | 机构20日流向(万元) | -26833.91 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量减少4541.95万股，其中基金净减仓49家，主力净增仓32家，暂未发现中长期投资价值。
截止2025-06-30，共284家主力机构（基金279家，一般法人5家），持仓量总计72422.29万股，占流通A股46.02%
其中，基金持仓与2024-12-31相比：
增仓：34家 ，增持 653.05万股
减仓：83家 ，减持 1052.66万股
新出现在主力名单中：144家 ，持有3529.34万股
从主力名单中消失：112家 ，原持有7849.96万股
其中，基金持仓与2024-12-31相比：
增仓：34家 ，增持 653.05万股
减仓：83家 ，减持 1052.66万股
新出现在主力名单中：144家 ，持有3529.34万股
从主力名单中消失：112家 ，原持有7849.96万股
消息面诊股
诊断结果：6.2消息面打败了85%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 华兰生物：10月13日获融资买入2746.49万元
2025-10-14 - 华兰生物：10月10日获融资买入1430.46万元
2025-10-13 - 华兰生物：10月9日获融资买入2703.62万元
2025-10-10 - 2025年中国血液制品行业十大潜力企业排行榜（附榜
2025-10-09 - 华兰生物：适时开展并购重组业务以提升公司质量和价值
2025-10-09 - 华兰生物：9月30日获融资买入3078.11万元
2025-10-09 - 华兰生物：9月29日获融资买入2480.86万元
2025-09-30 - 华兰生物：目前未有考虑在周边国家老挝缅甸尼珀尔巴基
2025-09-29 - 华兰生物：9月26日获融资买入1317.86万元
2025-09-29 - 中国“药王”，卖了1751亿元
2025-09-27
消息列表
| 一般消息 | 股东大会 | 临时股东大会 | 2025-08-28 |
| 利好 | 分红转增 | 10派5元(含税) | 2025-08-28 |
| 一般消息 | 募资投向 | 公司购买资产 | 2025-07-09 |
| 一般消息 | 重大事项 | 关联交易 | 2025-07-09 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-07-08 |
| 利好 | 分红转增 | 10派2元(含税) | 2025-03-29 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 2条 | 0条 | 2条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：5.2行业面打败了69%的股票
生物制品行业最新资金流向
近10日来该行业走势不明显，明显跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，明显跑输大盘。
[{"date":"2025.10.13","price":"-0.93","value":"-1.02"},{"date":"2025.10.10","price":"-2.70","value":"-0.88"},{"date":"2025.10.09","price":"1.47","value":"-0.38"},{"date":"2025.09.30","price":"0.35","value":"0.69"},{"date":"2025.09.29","price":"2.05","value":"0.77"},{"date":"2025.09.26","price":"-1.76","value":"-1.00"},{"date":"2025.09.25","price":"0.67","value":"-0.53"},{"date":"2025.09.24","price":"1.80","value":"1.74"},{"date":"2025.09.23","price":"-0.29","value":"-2.59"},{"date":"2025.09.22","price":"0.67","value":"-0.03"},{"date":"2025.09.19","price":"-0.04","value":"-1.89"},{"date":"2025.09.18","price":"-1.06","value":"-0.43"},{"date":"2025.09.17","price":"1.16","value":"-0.76"},{"date":"2025.09.16","price":"0.45","value":"-0.13"},{"date":"2025.09.15","price":"0.63","value":"-0.30"},{"date":"2025.09.12","price":"-0.43","value":"0.40"},{"date":"2025.09.11","price":"3.36","value":"0.93"},{"date":"2025.09.10","price":"0.38","value":"-0.72"},{"date":"2025.09.09","price":"-1.23","value":"-1.80"},{"date":"2025.09.08","price":"0.61","value":"0.58"},{"date":"2025.09.05","price":"3.89","value":"2.42"}]
深证成指,生物制品行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 康华生物 | 3.72% | -2.69% | 5.2分 |
| 2 | 长春高新 | 3.17% | 4.07% | 6.9分 |
| 3 | 荣昌生物 | 1.83% | -10.61% | 5.3分 |
| 4 | 辽宁成大 | 1.37% | 5.10% | 6.8分 |
| 5 | *ST四环 | 1.26% | 6.14% | 5.7分 |
| 6 | 东宝生物 | 0.00% | 4.66% | 6.1分 |
| 8 | 通化东宝 | -0.23% | 4.27% | 6.7分 |
| 10 | ST未名 | -0.93% | -7.91% | 4.4分 |
| 12 | 成大生物 | -1.45% | 0.26% | 5.8分 |
| 14 | 上海莱士 | -1.90% | 0.60% | 5.7分 |
| 16 | 近岸蛋白 | -2.96% | -2.08% | 5.4分 |
| 18 | 诺唯赞 | -3.10% | -1.79% | 6.0分 |
| 20 | 华兰生物 | -3.27% | 1.43% | 5.8分 |
| 22 | 卫光生物 | -4.09% | 1.51% | 5.5分 |
| 24 | 赛伦生物 | -5.40% | -0.61% | 5.8分 |
| 26 | 博晖创新 | -5.80% | -1.08% | 5.4分 |
| 28 | 西藏药业 | -5.90% | 3.71% | 5.7分 |
| 30 | 义翘神州 | -7.11% | -1.11% | 5.4分 |
| 32 | 华兰疫苗 | -7.25% | 1.53% | 5.9分 |
| 34 | 安科生物 | -8.17% | 2.20% | 5.6分 |
| 36 | 康希诺 | -9.19% | -1.47% | 5.5分 |
| 38 | 我武生物 | -11.24% | 2.78% | 5.9分 |
| 40 | 康弘药业 | -12.48% | -3.68% | 5.6分 |
| 42 | 凯因科技 | -12.59% | 0.47% | 5.5分 |
| 44 | - | -14.07% | 4.68% | 分 |
| 46 | 神州细胞 | -14.44% | -1.37% | 5.7分 |
| 48 | 诺诚健华 | -15.42% | -13.12% | 4.6分 |
| 50 | - | -17.94% | 0.89% | 分 |
| 52 | 君实生物 | -18.94% | -5.10% | 5.2分 |
| 54 | - | -26.65% | -5.94% | 分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2025-06-30 ]公司经营
盈利能力：较强，高于行业平均，两项指标的行业排名分别为 11/73 ， 40/73。
[{"date":"2025-06-30","value":"4.32","vol":"-1.13"},{"date":"2025-03-31","value":"2.61","vol":"0.46"},{"date":"2024-12-31","value":"9.37","vol":"-1.01"},{"date":"2024-09-30","value":"8.01","vol":"1.37"},{"date":"2024-06-30","value":"3.89","vol":"0.48"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
4.32 | 2.61 | 9.37 | 8.01 | 3.89 |
| 行业(%) | -1.13 | 0.46 | -1.01 | 1.37 | 0.48 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"52.58","vol":"66.99"},{"date":"2025-03-31","value":"56.28","vol":"68.43"},{"date":"2024-12-31","value":"61.45","vol":"68.53"},{"date":"2024-09-30","value":"61.77","vol":"70.57"},{"date":"2024-06-30","value":"50.69","vol":"68.37"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
52.58 | 56.28 | 61.45 | 61.77 | 50.69 |
| 行业(%) | 66.99 | 68.43 | 68.53 | 70.57 | 68.37 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：较强，高于行业平均，两项指标的行业排名分别为 24/73 ， 19/73。
[{"date":"2025-06-30","value":"8.80","vol":"6771.82"},{"date":"2025-03-31","value":"10.20","vol":"6125.27"},{"date":"2024-12-31","value":"-18.02","vol":"46.46"},{"date":"2024-09-30","value":"-10.79","vol":"178.44"},{"date":"2024-06-30","value":"4.26","vol":"19.00"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
8.80 | 10.20 | -18.02 | -10.79 | 4.26 |
| 行业(%) | 6771.82 | 6125.27 | 46.46 | 178.44 | 19.00 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"17.19","vol":"5.36"},{"date":"2025-03-31","value":"19.62","vol":"-8.46"},{"date":"2024-12-31","value":"-26.57","vol":"-8.35"},{"date":"2024-09-30","value":"-13.46","vol":"-53.42"},{"date":"2024-06-30","value":"-16.42","vol":"-8.90"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
17.19 | 19.62 | -26.57 | -13.46 | -16.42 |
| 行业(%) | 5.36 | -8.46 | -8.35 | -53.42 | -8.90 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：尚可，接近行业平均，两项指标的行业排名分别为 30/73 ， 29/73。
[{"date":"2025-06-30","value":"0.11","vol":"0.13"},{"date":"2025-03-31","value":"0.05","vol":"0.06"},{"date":"2024-12-31","value":"0.27","vol":"0.28"},{"date":"2024-09-30","value":"0.22","vol":"0.22"},{"date":"2024-06-30","value":"0.10","vol":"0.14"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.11 | 0.05 | 0.27 | 0.22 | 0.10 |
| 行业(次) | 0.13 | 0.06 | 0.28 | 0.22 | 0.14 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.39","vol":"0.55"},{"date":"2025-03-31","value":"0.18","vol":"0.26"},{"date":"2024-12-31","value":"0.91","vol":"1.15"},{"date":"2024-09-30","value":"0.75","vol":"0.87"},{"date":"2024-06-30","value":"0.45","vol":"0.54"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.39 | 0.18 | 0.91 | 0.75 | 0.45 |
| 行业(次) | 0.55 | 0.26 | 1.15 | 0.87 | 0.54 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：较强，高于行业平均，两项指标的行业排名分别为 16/73 ， 18/73。
[{"date":"2025-06-30","value":"23.25","vol":"-1377.61"},{"date":"2025-03-31","value":"1.63","vol":"-46.99"},{"date":"2024-12-31","value":"67.48","vol":"-9.01"},{"date":"2024-09-30","value":"7.53","vol":"-29.47"},{"date":"2024-06-30","value":"31.33","vol":"-36179.91"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 23.25 | 1.63 | 67.48 | 7.53 | 31.33 |
| 行业 | -1377.61 | -46.99 | -9.01 | -29.47 | -36179.91 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.80","vol":"1.56"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"0.94","vol":"2.00"},{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"1.94","vol":"2.68"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | 0.80 | - | 0.94 | - | 1.94 |
| 行业 | 1.56 | 0.00 | 2.00 | 0.00 | 2.68 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：较强，高于行业平均，两项指标的行业排名分别为 39/73 ， 32/73。
[{"date":"2025-06-30","value":"6.37","vol":"6.60"},{"date":"2025-03-31","value":"4.45","vol":"7.75"},{"date":"2024-12-31","value":"4.07","vol":"6.71"},{"date":"2024-09-30","value":"4.05","vol":"7.16"},{"date":"2024-06-30","value":"3.86","vol":"6.81"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 流动比率 |
6.37 | 4.45 | 4.07 | 4.05 | 3.86 |
| 行业 | 6.60 | 7.75 | 6.71 | 7.16 | 6.81 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"3.19","vol":"5.28"},{"date":"2025-03-31","value":"2.42","vol":"6.35"},{"date":"2024-12-31","value":"2.26","vol":"5.39"},{"date":"2024-09-30","value":"2.25","vol":"5.77"},{"date":"2024-06-30","value":"2.41","vol":"5.71"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 速动比率 |
3.19 | 2.42 | 2.26 | 2.25 | 2.41 |
| 行业 | 5.28 | 6.35 | 5.39 | 5.77 | 5.71 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：较强，高于行业平均，两项指标的行业排名分别为 38/73 ， 39/73。
[{"date":"2025-06-30","value":"10.07","vol":"26.48"},{"date":"2025-03-31","value":"14.82","vol":"26.03"},{"date":"2024-12-31","value":"15.10","vol":"25.56"},{"date":"2024-09-30","value":"14.85","vol":"24.92"},{"date":"2024-06-30","value":"15.55","vol":"24.23"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
10.07 | 14.82 | 15.10 | 14.85 | 15.55 |
| 行业(%) | 26.48 | 26.03 | 25.56 | 24.92 | 24.23 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.13","vol":"1.10"},{"date":"2025-03-31","value":"0.20","vol":"0.78"},{"date":"2024-12-31","value":"0.21","vol":"0.86"},{"date":"2024-09-30","value":"0.20","vol":"0.41"},{"date":"2024-06-30","value":"0.22","vol":"0.38"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.13 | 0.20 | 0.21 | 0.20 | 0.22 |
| 行业(%) | 1.10 | 0.78 | 0.86 | 0.41 | 0.38 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以增持为主，认为该股票有一定投资价值。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信建投证券 | 2025-09-17 | 买入 | |
| 国泰海通证券 | 2025-09-12 | 买入 | |
| 华泰金融(HK) | 2025-09-08 | 买入 | |
| 兴业证券 | 2025-09-07 | 增持 | |
| 野村东方国际证券 | 2025-09-02 | 增持 | |
| 华泰证券 | 2025-08-29 | 买入 |
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"12.99","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"10.76","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"14.82","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"10.88","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"12.75","blueLineValue":"0.70","type":"YC"}]